| Particulars | Mar2024 | Mar2023 | Mar2022 | Mar2021 |
|---|---|---|---|---|
| Revenue From Operations | 20,275.17 | 20,812.14 | 15,585.98 | 14,116.05 |
| Sale of Products | 19,843.53 | 20,394.63 | 15,518.50 | 13,988.40 |
| Sale of Services | 0.00 | 0.00 | 0.00 | 0.00 |
| Income from Investment and Financial Services | 0.00 | 0.00 | 0.00 | 0.00 |
| Particulars | Mar2024 | Mar2023 | Mar2022 | Mar2021 |
|---|---|---|---|---|
| Fixed Assets | 27,457.53 | 28,429.93 | 23,154.45 | 22,183.29 |
| Property, Plant and Equipments | 10,192.32 | 10,390.38 | 10,371.38 | 10,234.99 |
| Right-of-Use Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| Intangible Assets | 13,019.06 | 14,029.74 | 12,293.78 | 11,317.99 |
| Market Cap (Rs in Crs) | 4,24,706.28 | |
|---|---|---|
| P/E | 134.81 | |
| Book Value (Rs) | 98.33 | |
| Div (%) | 1350 | |
| Market Lot | 1 | |
| EPS (TTM) | 13.13 | |
|---|---|---|
| Price/Book | 18.00 | |
| Div Yield.(%) | 0.76 | |
| Face value (RS) | 1 | |
| Deliverables (%) | 22.12 | |
| Company Name | Market Cap (₹) | LTP (₹) | Prev. Close (₹) | Chg(%) |
52 Week H/L(₹)
|
|---|---|---|---|---|---|
| Divis Laborator... | 1,52,945.74 | 5,516.40 | 5,761.35 | -4.25 | 6,448.75 - 3,613.55 |
| Cipla Ltd | 1,20,750.87 | 1,417.15 | 1,495.15 | -5.22 | 1,702.00 - 1,317.60 |
| Torrent Pharmac... | 1,09,983.06 | 3,237.70 | 3,249.80 | -0.37 | 3,589.95 - 2,508.65 |
| Mankind Pharma ... | 1,00,167.88 | 2,425.20 | 2,427.85 | -0.11 | 3,050.00 - 1,910.10 |
| Dr Reddys Labor... | 96,066.67 | 1,105.00 | 1,151.25 | -4.02 | 1,420.20 - 1,093.00 |
Total Foreign
Total Institutions
Total Govt Holding
Total Non Promoter Corporate Holding
Total Promoters
Total Public & others
| Category | No. of Shares | Percentage |
|---|---|---|
| Total Foreign | 43,98,34,762 | 18.33 |
| Total Institutions | 44,50,47,053 | 18.55 |
| Total Govt Holding | 24,052 | 0.00 |
| Total Non Promoter Corporate Holding | 5,02,96,454 | 2.10 |
| Total Promoters | 1,30,71,34,535 | 54.48 |
| Total Public & others | 156998114 | 6.55 |
| Total | 2,39,93,34,970 | 100 |
